Clinical trial in duchenne dystrophy. I. The design of the protocol | Zendy

Brooke Michael H. | Zendy; Griggs Robert C. | Zendy; Mendell Jerry R. | Zendy; Fenichel Gerald M. | Zendy; Shumate Jack B. | Zendy; Pellegrino Richard J. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Clinical trial in duchenne dystrophy. I. The design of the protocol

Author(s) -

Brooke Michael H.,

Griggs Robert C.,

Mendell Jerry R.,

Fenichel Gerald M.,

Shumate Jack B.,

Pellegrino Richard J.

Publication year - 1981

Publication title -

muscle and nerve

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.025

H-Index - 145

eISSN - 1097-4598

pISSN - 0148-639X

DOI - 10.1002/mus.880040304

Subject(s) - duchenne muscular dystrophy , protocol (science) , clinical trial , muscular dystrophy , medicine , consistency (knowledge bases) , computer science , physical medicine and rehabilitation , artificial intelligence , pathology , alternative medicine

Therapeutic trials in muscular dystrophy have often been inconclusive. A protocol has been designed which selects patients with Duchenne muscular dystrophy and permits accurate measurement of their status. An integral part of the protocol is a system for checking on the consistency of the data obtained using a computer program.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research